J Healthc Manag 2017 Sep/Oct;62(5):302-313
Emma B. Holliday, MD, assistant professor, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston; James A. Bonner, MD, chair, Department of Radiation Oncology, University of Alabama, Birmingham; Silvia C. Formenti, MD, chair, Department of Radiation Oncology, Weill Cornell Medical College, New York, New York; Stephen M. Hahn, MD, chair, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center; Shalom Kalnicki, MD, chair, Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, New York; Fei-Fei Liu, MD, chair, Radiation Medicine Program, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada; Benjamin Movsas, MD, chair, Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan; Clifton D. Fuller, MD, PhD, associate professor, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center; and Charles R. Thomas, Jr., MD, chair, Department of Radiation Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland.